Gastrointestinal tumors (GIST) < 5 cm in size: Review of the literature and expert propositions for the clinical management;Tumeurs stromales gastro-intestinales (GIST) de taille limitée (inférieure à 5 cm) : revue de la littérature et propositions pour la prise en charge

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 2, 2010, Pages 120-133

  Landi, B ^a   Bouche O ^b   Guimbaud, R ^c   Chayvialle, J A ^d  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PLATELET DERIVED GROWTH FACTOR; STEM CELL FACTOR RECEPTOR;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; CAPSULE ENDOSCOPY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DOUBLE BALLOON ENTEROSCOPY; ENDOSCOPIC BIOPSY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; FOLLOW UP; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SURGERY; GENE MUTATION; HEMOPERITONEUM; HISTOPATHOLOGY; HUMAN; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL SPECIALIST; MITOSIS INDEX; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROGNOSIS; RISK ASSESSMENT; SHORT SURVEY; TUMOR LOCALIZATION; TUMOR VOLUME;

BIOPSY, FINE-NEEDLE; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL STROMAL TUMORS; HUMANS;

EID: 77249174745     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.06.019     Document Type: Short Survey

References (68)

1. Miettinen M., and Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438 (2001) 1-12
2. Lasota J., and Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol 23 (2006) 91-102
3. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130 (2006) 1466-1478
4. Blay J.Y., Landi B., Bonvalot S., Monges G., Ray-Coquard I., Duffaud F., et al. Recommendations for the management of GIST patients. Bull Cancer 92 (2005) 907-918
5. Casali P.G., Jost L., Reichardt P., Schlemmer M., and Blay J.Y. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 Suppl. 2 (2008) ii35-ii38
6. Demetri G.D., Benjamin R.S., Blanke C.D., Blay J.Y., Casali P., Choi H., et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5 Suppl. 2 (2007) S1-S29
7. Tumeurs stromales gastro-intestinales (GIST). Thésaurus national de cancérologie digestive. Disponible sur le site : www.snfge.asso.fr (consulté le 26 juin 2009).
8. Kawanowa K., Sakuma Y., Sakurai S., Hishima T., Iwasaki Y., Saito K., et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol 37 (2006) 1527-1535
9. Agaimy A., Wunsch P.H., Hofstaedter F., Blaszyk H., Rummele P., Gaumann A., et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 31 (2007) 113-120
10. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23 (2006) 70-83
11. Fletcher C.D., Berman J.J., Corless C., Gorstein F., Lasota J., Longley B.J., et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33 (2002) 459-465
12. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29 (2005) 52-68
13. Miettinen M., Makhlouf H., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 30 (2006) 477-489
14. Monges G., Coindre J., Scoazec J., Bouvier A., Blay J.Y., Loria-Kanza Y., et al. Incidence of gastrointestinal stromal tumors (GISTs) in France: results of the PROGIST survey conducted among pathologists (abstract). J Clin Oncol 25 18S (2007) 10047
15. Perez E.A., Livingstone A.S., Franceschi D., Rocha-Lima C., Lee D.J., Hodgson N., et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg 202 (2006) 623-629
16. Nilsson B., Bumming P., Meis-Kindblom J.M., Oden A., Dortok A., Gustavsson B., et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden. Cancer 103 (2005) 821-829
17. Tryggvason G., Gislason H.G., Magnusson M.K., and Jonasson J.G. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer 117 (2005) 289-293
18. Goettsch W.G., Bos S.D., Breekveldt-Postma N., Casparie M., Herings R.M., and Hogendoorn P.C. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. Eur J Cancer 41 (2005) 2868-2872
19. DeMatteo R.P., Lewis J.J., Leung D., Mudan S.S., Woodruff J.M., and Brennan M.F. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231 (2000) 51-58
20. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39 (2008) 1411-1419
21. Ludwig D.J., and Traverso L.W. Gut stromal tumors and their clinical behavior. Am J Surg 173 (1997) 390-394
22. O'Sullivan P.J., Harris A.C., Ho S.G., and Munk P.L. The imaging features of gastrointestinal stromal tumours. Eur J Radiol 60 (2006) 431-438
23. Polkowski M., and Butruk E. Submucosal lesions. Gastrointest Endosc Clin N Am 15 (2005) 33-54 viii
24. Hunt G.C., Smith P.P., and Faigel D.O. Yield of tissue sampling for submucosal lesions evaluated by EUS. Gastrointest Endosc 57 (2003) 68-72
25. Cantor M.J., Davila R.E., and Faigel D.O. Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. Gastrointest Endosc 64 (2006) 29-34
26. Kojima T., Takahashi H., Parra-Blanco A., Kohsen K., and Fujita R. Diagnosis of submucosal tumor of the upper GI tract by endoscopic resection. Gastrointest Endosc 50 (1999) 516-522
27. Brand B., Oesterhelweg L., Binmoeller K.F., Sriram P.V., Bohnacker S., Seewald S., et al. Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. Dig Liver Dis 34 (2002) 290-297
28. Nickl N. Endoscopic approach to gastrointestinal stromal tumors. Gastrointest Endosc Clin N Am 15 (2005) 455-466 viii
29. Landi B., and Cellier C. Tumeurs stromales gastriques : qu'apporte l'écho-endoscopie à l'heure de la biologie moléculaire ?. Acta Endoscopica 34 (2004) 1-5
30. Zhu X., Zhang X.Q., Li B.M., Xu P., Zhang K.H., and Chen J. Esophageal mesenchymal tumors: endoscopy, pathology and immunohistochemistry. World J Gastroenterol 13 (2007) 768-773
31. Hwang J.H., Rulyak S.D., and Kimmey M.B. American Gastroenterological Association Institute technical review on the management of gastric subepithelial masses. Gastroenterology 130 (2006) 2217-2228
32. Kimmey M.B., Martin R.W., Haggitt R.C., Wang K.Y., Franklin D.W., and Silverstein F.E. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology 96 (1989) 433-441
33. Hunt G.C., Rader A.E., and Faigel D.O. A comparison of EUS features between CD-117 positive GI stromal tumors and CD-117 negative GI spindle cell tumors. Gastrointest Endosc 57 (2003) 469-474
34. Okai T., Minamoto T., Ohtsubo K., Minato H., Kurumaya H., Oda Y., et al. Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor. Abdom Imaging 28 (2003) 301-307
35. Chak A., Canto M.I., Rosch T., Dittler H.J., Hawes R.H., Tio T.L., et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 45 (1997) 468-473
36. Melzer E., and Fidder H. The natural course of upper gastrointestinal submucosal tumors: an endoscopic ultrasound survey. Isr Med Assoc J 2 (2000) 430-432
37. Mochizuki Y., Kodera Y., Ito S., Yamamura Y., Kanemitsu Y., Shimizu Y., et al. Treatment and risk factors for recurrence after curative resection of gastrointestinal stromal tumors of the stomach. World J Surg 28 (2004) 870-875
38. Ueyama T., Kawamoto K., Iwashita I., Masuda K., Haraguchi Y., Oiwa T., et al. Correlation between tumor volume doubling time and histologic findings in gastric smooth muscle tumors: clinical implications of tumor volume doubling time. J Surg Oncol 60 (1995) 12-17
39. Chak A. EUS in submucosal tumors. Gastrointest Endosc 56 (2002) S43-S48
40. Palazzo L., Landi B., Cellier C., Cuillerier E., Roseau G., and Barbier J.P. Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut 46 (2000) 88-92
41. Jeon S.W., Park Y.D., Chung Y.J., Cho C.M., Tak W.Y., Kweon Y.O., et al. Gastrointestinal stromal tumors of the stomach: endosonographic differentiation in relation to histological risk. J Gastroenterol Hepatol 22 (2007) 2069-2075
42. Ando N., Goto H., Niwa Y., Hirooka Y., Ohmiya N., Nagasaka T., et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 55 (2002) 37-43
43. Chen V.K., and Eloubeidi M.A. Endoscopic ultrasound-guided fine-needle aspiration of intramural and extraintestinal mass lesions: diagnostic accuracy, complication assessment, and impact on management. Endoscopy 37 (2005) 984-989
44. Vander III N.M., Eloubeidi M.A., Chen V.K., Eltoum I., Jhala D., Jhala N., et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 102 (2004) 157-163
45. Stelow E.B., Stanley M.W., Mallery S., Lai R., Linzie B.M., and Bardales R.H. Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol 119 (2003) 703-708
46. Okubo K., Yamao K., Nakamura T., Tajika M., Sawaki A., Hara K., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach. J Gastroenterol 39 (2004) 747-753
47. Willmore-Payne C., Layfield L.J., and Holden J.A. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. Cancer 105 (2005) 165-170
48. Ponsaing L.G., Kiss K., Loft A., Jensen L.I., and Hansen M.B. Diagnostic procedures for submucosal tumors in the gastrointestinal tract. World J Gastroenterol 13 (2007) 3301-3310
49. Polkowski M. Endoscopic diagnosis and treatment of upper gastrointestinal tumors. Endoscopy 38 (2006) 1070-1075
50. Sun S., Ge N., Wang C., Wang M., and Lu Q. Endoscopic band ligation of small gastric stromal tumors and follow-up by endoscopic ultrasonography. Surg Endosc 21 (2007) 574-578
51. Park Y.S., Park S.W., Kim T.I., Song S.Y., Choi E.H., Chung J.B., et al. Endoscopic enucleation of upper-GI submucosal tumors by using an insulated-tip electrosurgical knife. Gastrointest Endosc 59 (2004) 409-415
52. Lee I.L., Lin P.Y., Tung S.Y., Shen C.H., Wei K.L., and Wu C.S. Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer. Endoscopy 38 (2006) 1024-1028
53. Wehrmann T., Martchenko K., Nakamura M., Riphaus A., and Stergiou N. Endoscopic resection of submucosal esophageal tumors: a prospective case series. Endoscopy 36 (2004) 802-807
54. Novitsky Y.W., Kercher K.W., Sing R.F., and Heniford B.T. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 243 (2006) 738-745
55. Wilhelm D., von Delius S., Burian M., Schneider A., Frimberger E., Meining A., et al. Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg 32 (2008) 1021-1028
56. Rosch T., Kapfer B., Will U., Baronius W., Strobel M., Lorenz R., et al. Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand J Gastroenterol 37 (2002) 856-862
57. Royster J.D. AGAI technical review statements regarding GIST are troubling. Gastroenterology 132 (2007) 822-823
58. Hassan I., You Y.N., Dozois E.J., Shayyan R., Smyrk T.C., Okuno S.H., et al. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Colon Rectum 49 (2006) 609-615
59. Changchien C.R., Wu M.C., Tasi W.S., Tang R., Chiang J.M., Chen J.S., et al. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Colon Rectum 47 (2004) 1922-1929
60. Miettinen M., Furlong M., Sarlomo-Rikala M., Burke A., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 25 (2001) 1121-1133
61. Miettinen M., Kopczynski J., Makhlouf H.R., Sarlomo-Rikala M., Gyorffy H., Burke A., et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27 (2003) 625-641
62. Wardelmann E., Buttner R., Merkelbach-Bruse S., and Schildhaus H.U. Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy. Virchows Arch 451 (2007) 743-749
63. Lasota J., vel Dobosz A.J., Wasag B., Wozniak A., Kraszewska E., Michej W., et al. Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors. Lab Invest 87 (2007) 1029-1041
64. Andersson J., Bumming P., Meis-Kindblom J.M., Sihto H., Nupponen N., Joensuu H., et al. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis. Gastroenterology 130 (2006) 1573-1581
65. Lasota J., Dansonka-Mieszkowska A., Sobin L.H., and Miettinen M. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 84 (2004) 874-883
66. Yamaguchi U., Nakayama R., Honda K., Ichikawa H., Hasegawa T., Shitashige M., et al. Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 26 (2008) 4100-4108
67. Yamada M., Niwa Y., Matsuura T., Miyahara R., Ohashi A., Maeda O., et al. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy. Scand J Gastroenterol 42 (2007) 633-641
68. Demetri G.D., Benjamin R.S., Blanke C.D., et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5 Suppl. 2 (2007) S1-S29